Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mingzhen Zhou

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Journal of Hepatocellular Carcinoma|November 4, 2024
Circulating Biomarkers Predict Immunotherapeutic Response in Hepatocellular Carcinoma Using a Machine Learning MethodZhiyan Dai, Chao Chen, Ziyan Zhou, et al.
Inflammation|March 16, 2024
An Advanced Intrahepatic Cholangiocarcinoma Patient Benefits from Personalized ImmunotherapySihui Zhu, Chenxi Liu, Yunchen Jin, et al.
Oncotarget|March 19, 2016
Radiation dose escalation by simultaneous modulated accelerated radiotherapy combined with chemotherapy for esophageal cancer: a phase II studyJianzhou Chen, Hong Guo, Tiantian Zhai, et al.
Cancer Immunology, Immunotherapy : CII|July 3, 2026
Multidimensional analysis of tumour immune microenvironment in HCC: prognostic significance and implications for immunotherapyJun Chen, Mingzhen Zhou, Wenyan Cao, et al.
Cancer Research|September 24, 2025
Extracellular Vesicle-Packaged miR-99a Reprograms Fibroblasts to Create an Inflammatory Niche That Drives Colorectal Cancer MetastasisMingzhen Zhou, Hao Liu, Juan Hui, et al.
Cell Death & Disease|January 31, 2026
SLC46A1 deficiency-mediated folate restriction suppresses colorectal cancer progression through epigenetic-transcriptional reprogrammingYelu Zhou, Yanxing Liu, Yi Liu, et al.
Cancer Letters|July 20, 2025
SMARCA1-NPFF axis inhibits colorectal cancer metastasis by blocking epithelial-mesenchymal transition and macrophage-dependent immune reprogrammingHaojia Wang, Shuya Du, Songtao Ji, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Journal of Hepatocellular Carcinoma|November 4, 2024
Circulating Biomarkers Predict Immunotherapeutic Response in Hepatocellular Carcinoma Using a Machine Learning MethodZhiyan Dai, Chao Chen, Ziyan Zhou, et al.
Inflammation|March 16, 2024
An Advanced Intrahepatic Cholangiocarcinoma Patient Benefits from Personalized ImmunotherapySihui Zhu, Chenxi Liu, Yunchen Jin, et al.
Oncotarget|March 19, 2016
Radiation dose escalation by simultaneous modulated accelerated radiotherapy combined with chemotherapy for esophageal cancer: a phase II studyJianzhou Chen, Hong Guo, Tiantian Zhai, et al.
Cancer Immunology, Immunotherapy : CII|July 3, 2026
Multidimensional analysis of tumour immune microenvironment in HCC: prognostic significance and implications for immunotherapyJun Chen, Mingzhen Zhou, Wenyan Cao, et al.
Cancer Research|September 24, 2025
Extracellular Vesicle-Packaged miR-99a Reprograms Fibroblasts to Create an Inflammatory Niche That Drives Colorectal Cancer MetastasisMingzhen Zhou, Hao Liu, Juan Hui, et al.
Cell Death & Disease|January 31, 2026
SLC46A1 deficiency-mediated folate restriction suppresses colorectal cancer progression through epigenetic-transcriptional reprogrammingYelu Zhou, Yanxing Liu, Yi Liu, et al.
Cancer Letters|July 20, 2025
SMARCA1-NPFF axis inhibits colorectal cancer metastasis by blocking epithelial-mesenchymal transition and macrophage-dependent immune reprogrammingHaojia Wang, Shuya Du, Songtao Ji, et al.
Pageof 3